Aditya Bharadwaj1, Jessica Potts2, Mohamed O Mohamed2, Purvi Parwani1, Pooja Swamy1, Juan C Lopez-Mattei3, Muhammad Rashid2, Chun Shing Kwok2, David L Fischman4, Vassilios S Vassiliou5, Philip Freeman6, Erin D Michos7,8, Mamas A Mamas2. 1. Division of Cardiology, Department of Medicine, Loma Linda University, 11234 Anderson St, Loma Linda, CA 92354, USA. 2. Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, ST5 5BG, UK. 3. Department of Cardiology, Division of Internal Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. 4. Department of Medicine (Cardiology), Thomas Jefferson University Hospital, 111 S 11th St, Philadelphia, PA 19107, USA. 5. Department of Cardiology, Norwich Medical School, University of East Anglia, Bob Champion Research and Education, Norwich NR4 7TJ, UK. 6. Cardiology Department, Aalborg University Hospital, Hobrovej 18-22, 9100 Aalborg, Denmark. 7. Department of Medicine (Cardiology), Johns Hopkins School of Medicine, 733 N Broadway, Baltimore, MD 21205, USA. 8. Department of Cardiology, Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, 733 N Broadway, Baltimore, MD 21205, USA.
Abstract
AIMS: The aim of this study is to evaluate temporal trends, treatment, and clinical outcomes of patients who present with an acute myocardial infarction (AMI) and have a current or historical diagnosis of cancer, according to cancer type and presence of metastases. METHODS AND RESULTS: Data from 6 563 255 patients presenting with an AMI between 2004 and 2014 from the US National Inpatient Sample (NIS) database were analysed. A total of 5 966 955 had no cancer, 186 604 had current cancer, and 409 697 had a historical diagnosis of cancer. Prostate, breast, colon, and lung cancer were the four most common types of cancer. Patients with cancer were older with more comorbidities. Differences in invasive treatment were noted, 43.9% received percutaneous coronary intervention (PCI) in patients without cancer, whilst only 21.0% of patients with lung cancer received PCI. Lung cancer was associated with the highest in-hospital mortality [odds ratio (OR) 2.71, 95% confidence interval (CI) 2.62-2.80], major adverse cardiovascular and cerebrovascular complications (OR 2.38, 95% CI 2.31-2.45), and stroke (OR 1.91, 95% CI 1.80-2.02), while colon cancer was associated with highest risk of bleeding (OR 2.82, 95% CI 2.68-2.98). Irrespective of the type of cancer, presence of metastasis was associated with worse in-hospital outcomes, and historical cancer did not adversely impact on survival (OR 0.90, 95% CI 0.89-0.91). CONCLUSION: A concomitant cancer diagnosis is associated with a conservative medical management strategy for AMI, and worse clinical outcomes, compared to patients without cancer. Survival and clinical outcomes in the context of AMI vary significantly according to the type of cancer and metastasis status. The management of this high-risk group is challenging and requires a multidisciplinary and patient-centred approach to improve their outcomes. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The aim of this study is to evaluate temporal trends, treatment, and clinical outcomes of patients who present with an acute myocardial infarction (AMI) and have a current or historical diagnosis of cancer, according to cancer type and presence of metastases. METHODS AND RESULTS: Data from 6 563 255 patients presenting with an AMI between 2004 and 2014 from the US National Inpatient Sample (NIS) database were analysed. A total of 5 966 955 had no cancer, 186 604 had current cancer, and 409 697 had a historical diagnosis of cancer. Prostate, breast, colon, and lung cancer were the four most common types of cancer. Patients with cancer were older with more comorbidities. Differences in invasive treatment were noted, 43.9% received percutaneous coronary intervention (PCI) in patients without cancer, whilst only 21.0% of patients with lung cancer received PCI. Lung cancer was associated with the highest in-hospital mortality [odds ratio (OR) 2.71, 95% confidence interval (CI) 2.62-2.80], major adverse cardiovascular and cerebrovascular complications (OR 2.38, 95% CI 2.31-2.45), and stroke (OR 1.91, 95% CI 1.80-2.02), while colon cancer was associated with highest risk of bleeding (OR 2.82, 95% CI 2.68-2.98). Irrespective of the type of cancer, presence of metastasis was associated with worse in-hospital outcomes, and historical cancer did not adversely impact on survival (OR 0.90, 95% CI 0.89-0.91). CONCLUSION: A concomitant cancer diagnosis is associated with a conservative medical management strategy for AMI, and worse clinical outcomes, compared to patients without cancer. Survival and clinical outcomes in the context of AMI vary significantly according to the type of cancer and metastasis status. The management of this high-risk group is challenging and requires a multidisciplinary and patient-centred approach to improve their outcomes. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Daniel Finke; Markus B Heckmann; Susanna Wilhelm; Lukas Entenmann; Hauke Hund; Nina Bougatf; Hugo A Katus; Norbert Frey; Lorenz H Lehmann Journal: Clin Res Cardiol Date: 2022-03-21 Impact factor: 5.460
Authors: Mohammed Osman; Mina M Benjamin; Sudarshan Balla; Babikir Kheiri; Christopher Bianco; Partho P Sengupta; Ramesh Daggubati; Midhun Malla; Stephen V Liu; Mamas Mamas; Brijesh Patel Journal: Cardiovasc Revasc Med Date: 2021-04-16
Authors: Hashrul N Rashid; Michael Michail; Abdul R Ihdayhid; Cameron Dowling; Nancy Khav; Sean Tan; Jaineel Ramnarain; James D Cameron; Arthur Nasis; Stephen J Nicholls; Robert P Gooley Journal: Heart Vessels Date: 2021-03-04 Impact factor: 2.037
Authors: Juan C Lopez-Mattei; Eric H Yang; Maros Ferencik; Lauren A Baldassarre; Susan Dent; Matthew J Budoff Journal: JACC CardioOncol Date: 2021-12-21
Authors: Isabela Bispo Santos da Silva Costa; Fernanda Thereza de Almeida Andrade; Diego Carter; Vinicius B Seleme; Maycon Santos Costa; Carlos M Campos; Ludhmila Abrahão Hajjar Journal: Front Cardiovasc Med Date: 2021-06-09